SCHEMBL3376596

SCHEMBL3376596

CCCC(O)C1(C)COC1

nearest known ligand 0.36

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3421813 0.87 EPHX1 (0.33) EPHX1
SCHEMBL3418335 0.85 GPR84 (0.35)
SCHEMBL3418446 0.84 GPR84 (0.38)
SCHEMBL1011191 0.81
SCHEMBL11981880 0.78
SCHEMBL3414473 0.76 EPHX1 (0.30) EPHX1
SCHEMBL11981981 0.74
SCHEMBL11981965 0.74
SCHEMBL28895319 0.74
SCHEMBL3420552 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4435064-B1 NONAQUEOUS INKJET INK AND METHOD FOR FORMING CURED PRODUCT KONICA MINOLTA INC (JP) 2026-04-22 EP disclosed
EP-4711426-A1 ACTIVE RAY-CURABLE INKJET INK COMPOSITION, METHOD FOR FORMING INSULATING FILM, INSULATING FILM, AND PRINTED WIRING BOARD KONICA MINOLTA, INC. (JP) 2026-03-18 EP disclosed
EP-4603551-A1 INKJET INK AND METHOD FOR PRODUCING THE SAME, METHOD FOR FORMING CURED PRODUCT, AND METHOD FOR STIRRING INKJET INK KONICA MINOLTA, INC. (JP) 2025-08-20 EP disclosed
EP-4600317-A1 INKJET INK, METHODS FOR PRODUCING PIGMENT DISPERSION AND INKJET INK, METHOD FOR FORMING CURED PRODUCT, AND CURED PRODUCT KONICA MINOLTA, INC. (JP) 2025-08-13 EP disclosed
EP-4534615-A1 ULTRAVIOLET CURABLE INK, METHOD FOR FORMING CURED PRODUCT, CURED PRODUCT, AND APPARATUS FOR FORMING CURED PRODUCT KONICA MINOLTA, INC. (JP) 2025-04-09 EP disclosed
EP-4530322-A1 INKJET INK, METHOD FOR FORMING CURED PRODUCT, AND CURED PRODUCT KONICA MINOLTA, INC. (JP) 2025-04-02 EP disclosed
CN-119708917-A Inkjet ink, method for forming cured product, and cured product 柯尼卡美能达株式会社 2025-03-28 CN disclosed
EP-4524210-A1 INKJET INK AND IMAGE FORMING METHOD KONICA MINOLTA, INC. (JP) 2025-03-19 EP disclosed
US-20250084271-A1 INKJET INK AND IMAGE FORMING METHOD Konica Minolta, Inc. (JP) 2025-03-13 US disclosed
WO-2025048099-A1 CURABLE COMPOSITION, CURED LAYER PRODUCED USING COMPOSITION AND DISPLAY DEVICE INCLUDING CURED LAYER 삼성에스디아이 주식회사 2025-03-06 WO disclosed
US-8338074-B2 Actinic radiation-curable stereolithographic resin composition having improved stability CMET INC. (JP) 2012-12-25 US disclosed
US-20100130712-A1 ADAMANTANE DERIVATIVE, RESIN COMPOSITION USING THE SAME, AND RESIN CURED PRODUCT IDEMITSU KOSAN CO., LTD. (JP) 2010-05-27 US disclosed
US-20100104804-A1 Three-Dimensional Object Having Smoothed Fabricated Edge Surface CMET INC. (JP) 2010-04-29 US disclosed
US-7690783-B2 Ink for inkjet printing, lithographic printing plate using it and method for making such plate FUJIFILM CORPORATION (JP) 2010-04-06 US disclosed
US-7354643-B2 Three-dimensional object and method of producing the same CMET INC. (JP) 2008-04-08 US disclosed
EP-1902829-A1 THREE-DIMENSIONAL SHAPED ITEM WITH SMOOTHED MOLDING END FACE Cmet Inc. (JP) 2008-03-26 EP disclosed
US-20070060682-A1 Actinic radiation-curable stereolithographic resin composition having improved stability CMET INC. (JP) 2007-03-15 US disclosed
EP-1693427-A2 Ink for inkjet printing, lithographic printing plate using it and method for making such plate FUJI PHOTO FILM CO., LTD. (JP) 2006-08-23 EP disclosed
US-20060181591-A1 Ink for inkjet printing, lithographic printing plate using it and method for making such plate FUJI PHOTO FILM CO., LTD. 2006-08-17 US disclosed
US-20060141276-A1 Three-dimensional structure and method for production thereof CMET INC. (JP) 2006-06-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100130712-A1 ADAMANTANE DERIVATIVE, RESIN COMPOSITION USING THE SAME, AND RESIN CURED PRODUCT ARCN1, APP, ADAM17 EPHX1 55/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.